FNY Investment Advisers’s BioVie BIVI Stock Holding History

FNY Investment Advisers’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-90	Closed	-$38K	–	619
2023 Q2	$38K	Buy	+90	New	+$60.6K	0.05%	186
2023 Q1	–	Sell	-142	Closed	-$110K	–	566
2022 Q4	$110K	Buy	+142	New	+$76.8K	0.15%	129

Other funds holding BIVI

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Investment Advisers's BIVI Position: Q3 2023 in Review

FNY Investment Advisers sold out of BioVie (BIVI) in Q3 2023, closing a stake of 90 shares — an estimated $38K sold.

FNY Investment Advisers first reported a position in BIVI in Q4 2022 and held it in 2 quarters. The position peaked at $110K in Q4 2022. 56 funds tracked by Wall St. Rank hold BIVI as of Q3 2023.

FNY Investment Advisers reported no remaining BioVie position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 90 BioVie shares in Q3 2023, an estimated $38K.
FNY Investment Advisers first reported a position in BioVie in Q4 2022 and held it in 2 quarters.
FNY Investment Advisers's BioVie position peaked at $110K in Q4 2022.
56 funds tracked by Wall St. Rank held BioVie as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.